Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-06-15 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | -10,00k | 0,00 | Other Disposition | - | 579,66k | -1,70% |
| 2026-06-08 | Sylebra Capital LimitedSocietà | -64,63k | 8,30M | Vendita | 125,97 - 130,07 | 775,94k | -7,69% |
| 2026-06-05 | Sylebra Capital LimitedSocietà | -47,48k | 5,89M | Vendita | 122,50 - 128,87 | 840,58k | -5,35% |
| 2026-05-26 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | -180,00k | 28,20M | Other Disposition | 156,68 | 589,66k | -23,39% |
| 2026-06-04 | Sylebra Capital LimitedSocietà | -33,41k | 4,57M | Vendita | 136,84 | 888,06k | -3,63% |
| 2026-06-02 | Sylebra Capital LimitedSocietà | -45,04k | 6,39M | Vendita | 139,17 - 142,31 | 921,47k | -4,66% |
| 2026-05-29 | Sylebra Capital LimitedSocietà | -55,67k | 8,35M | Vendita | 144,29 - 150,78 | 966,50k | -5,45% |
| 2026-05-28 | Mr. Daniel Patrick GibsonIndependent Director | 3,11k | 0,00 | Derivative Exercise and Retained Stock | - | 23,01k | 15,65% |
| 2026-05-28 | Mr. Miron L. WashingtonIndependent Director | 3,11k | 0,00 | Derivative Exercise and Retained Stock | - | 5,15k | 152,65% |
| 2026-05-28 | Mr. Umesh PadvalIndependent Director | 3,11k | 0,00 | Derivative Exercise and Retained Stock | - | 6,65k | 87,97% |
| 2026-05-28 | Mr. Stephen SanghiIndependent Chair of the Board | 3,43k | 0,00 | Derivative Exercise and Retained Stock | - | 53,47k | 6,84% |
| 2026-05-28 | Ms. Meera P. RaoIndependent Director | 3,11k | 0,00 | Derivative Exercise and Retained Stock | - | 11,32k | 37,94% |
| 2026-05-08 | Sylebra Capital LimitedSocietà | -73,81k | 11,31M | Vendita | 149,97 - 154,46 | 1,02M | -6,73% |
| 2026-05-07 | Sylebra Capital LimitedSocietà | -72,34k | 11,05M | Vendita | 152,73 | 1,10M | -6,19% |
| 2026-03-23 | Mr. Cary L. BakerCFO | 1,13k | 0,00 | Derivative Exercise and Retained Stock | - | 89,00k | 1,28% |
| 2026-03-23 | Mr. Cary L. BakerCFO | -732,00 | 74,06k | Derivative Exercise and Sale | 101,17 | 89,00k | - |
| 2026-03-23 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | 3,42k | 0,00 | Derivative Exercise and Retained Stock | - | 589,66k | 0,58% |
| 2026-03-23 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | -2,22k | 224,40k | Derivative Exercise and Sale | 101,17 | 589,66k | - |
| 2026-02-20 | Mr. Cary L. BakerCFO | -2,23k | 285,77k | Sale to Issuer | 127,92 | 87,88k | -2,48% |
| 2026-02-20 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | -7,44k | 951,09k | Sale to Issuer | 127,92 | 586,25k | -1,25% |
| 2026-02-17 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | -1,84k | 0,00 | Other Disposition | - | 571,95k | -0,32% |
| 2025-12-23 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | 3,42k | 0,00 | Derivative Exercise and Retained Stock | - | 573,78k | 0,60% |
| 2025-12-23 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | -2,22k | 381,47k | Derivative Exercise and Sale | 171,99 | 573,78k | - |
| 2025-12-23 | Mr. Cary L. BakerCFO | 1,12k | 0,00 | Derivative Exercise and Retained Stock | - | 81,60k | 1,40% |
| 2025-12-23 | Mr. Cary L. BakerCFO | -732,00 | 125,90k | Derivative Exercise and Sale | 171,99 | 81,60k | - |
| 2025-12-11 | Sylebra Capital LimitedSocietà | -280,55k | 42,23M | Vendita | 146,62 - 152,87 | 1,13M | -19,86% |
| 2025-12-08 | Sylebra Capital LimitedSocietà | -87,14k | 13,56M | Vendita | 155,49 - 160,72 | 1,41M | -5,81% |
| 2025-12-03 | Sylebra Capital LimitedSocietà | -45,76k | 7,65M | Vendita | 160,59 - 167,97 | 1,50M | -2,96% |
| 2025-12-01 | Sylebra Capital LimitedSocietà | -72,93k | 12,23M | Vendita | 167,02 - 168,23 | 1,55M | -4,51% |
| 2025-11-26 | Sylebra Capital LimitedSocietà | -56,85k | 9,79M | Vendita | 171,80 - 172,62 | 1,62M | -3,39% |
| 2025-11-24 | Sylebra Capital LimitedSocietà | -78,06k | 12,83M | Vendita | 159,42 - 167,73 | 1,68M | -4,45% |
| 2025-11-25 | Mr. Cary L. BakerCFO | -1.000,00 | 0,00 | Other Disposition | - | 80,48k | -1,23% |
| 2025-11-20 | Sylebra Capital LimitedSocietà | -11,13k | 1,74M | Vendita | 155,10 - 156,32 | 1,75M | -0,63% |
| 2025-11-19 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | -7,00k | 0,00 | Other Disposition | - | 570,37k | -1,21% |
| 2025-11-12 | Sylebra Capital LimitedSocietà | -3,77k | 589,56k | Vendita | 156,30 | 1,76M | -0,21% |
| 2025-11-11 | Sylebra Capital LimitedSocietà | -30,00k | 4,67M | Vendita | 155,63 | 1,77M | -1,67% |
| 2025-11-07 | Sylebra Capital LimitedSocietà | -6,25k | 1,01M | Vendita | 162,16 | 1,80M | -0,35% |
| 2025-11-06 | Sylebra Capital LimitedSocietà | -23,16k | 3,98M | Vendita | 171,95 | 1,80M | -1,27% |
| 2025-11-07 | Mr. Miron L. WashingtonIndependent Director | -342,00 | 54,36k | Vendita | 158,94 | 2,04k | -14,36% |
| 2025-11-03 | Sylebra Capital LimitedSocietà | -1,51k | 305,64k | Vendita | 202,01 | 1,83M | -0,08% |
| 2025-10-30 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | 23,50k | 526,40k | Derivative Exercise and Retained Stock | 22,40 | 577,37k | 4,24% |
| 2025-09-23 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | 3,42k | 0,00 | Derivative Exercise and Retained Stock | - | 553,87k | 0,62% |
| 2025-09-23 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | -2,22k | 410,45k | Derivative Exercise and Sale | 184,97 | 553,87k | - |
| 2025-09-23 | Mr. Cary L. BakerCFO | 1,13k | 0,00 | Derivative Exercise and Retained Stock | - | 81,48k | 1,40% |
| 2025-09-23 | Mr. Cary L. BakerCFO | -732,00 | 135,40k | Derivative Exercise and Sale | 184,97 | 81,48k | - |
| 2025-09-18 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | 54,08k | 1,75M | Derivative Exercise and Retained Stock | 22,40 - 33,77 | 550,45k | 10,89% |
| 2025-09-15 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | -9,10k | 1,68M | Automatic Disposition | 179,26 - 191,76 | 496,38k | -1,80% |
| 2025-09-12 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | -30,00k | 0,00 | Other Disposition | - | 496,38k | -5,70% |
| 2025-09-10 | Sylebra Capital LimitedSocietà | -300,00k | 58,87M | Vendita | 196,24 | 1,83M | -14,09% |
| 2025-09-08 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | -10,00k | 1,94M | Automatic Disposition | 190,42 - 199,77 | 535,47k | -1,83% |
| 2025-09-02 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | -10,00k | 1,85M | Automatic Disposition | 180,56 - 190,15 | 545,47k | -1,80% |
| 2025-08-28 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | -10,00k | 1,88M | Automatic Disposition | 185,93 - 190,79 | 555,47k | -1,77% |
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
